Get comprehensive genetic testing for Myelodysplastic Syndrome with the Oncomine MDS Panel Test for only $1024 USD. Advanced NGS technology detects 40+ genetic mutations associated with MDS and leukemia. Available nationwide across USA including New York
Get comprehensive Nx Gen Sequencing Tuberous Sclerosis Complex testing for only $688 USD. Advanced genetic screening for TSC1 and TSC2 mutations with 30-day results. Available across major US cities including New York Nx Gen Sequencing Tuberous Sclerosis Complex Test Original price was: $764.Current price is: $688.
Get accurate Pan Fungal Detection PCR Test for $162 USD in USA. Advanced molecular testing detects fungal infections in blood Pan Fungal Detection PCR Test Original price was: $250.Current price is: $162.
Sale!

Oncomine Myelodysplastic Syndrome MDS Panel Test

Original price was: $1,138.Current price is: $1,024.

-10%

The Oncomine Myelodysplastic Syndrome MDS Panel Test is a comprehensive next-generation sequencing (NGS) analysis that detects genetic mutations associated with myelodysplastic syndromes and related blood disorders. This advanced diagnostic test examines over 40 key genes including ASXL1, DNMT3A, TP53, and SF3B1, providing crucial information for accurate diagnosis, prognosis assessment, and treatment planning. The test is particularly valuable for patients with unexplained cytopenias, abnormal blood counts, or suspected MDS. Results help hematologists and oncologists develop personalized treatment strategies and monitor disease progression. The test is available for $1024 USD and provides detailed genetic profiling essential for modern hematologic care.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

Oncomine Myelodysplastic Syndrome MDS Panel Test

Comprehensive Genetic Testing for Myelodysplastic Syndromes

The Oncomine Myelodysplastic Syndrome MDS Panel Test represents a cutting-edge diagnostic approach in hematologic oncology. This sophisticated next-generation sequencing (NGS) panel provides comprehensive genetic profiling specifically designed for patients with suspected or confirmed myelodysplastic syndromes (MDS). MDS encompasses a group of diverse bone marrow disorders characterized by ineffective blood cell production and increased risk of progression to acute myeloid leukemia.

What Does the Oncomine MDS Panel Test Measure?

This advanced genetic panel analyzes over 40 critical genes associated with MDS pathogenesis and progression. The comprehensive analysis includes:

  • Epigenetic Regulators: ASXL1, DNMT3A, EZH2, TET2, IDH1, IDH2
  • Spliceosome Components: SF3B1, SRSF2, U2AF1, ZRSR2
  • Transcription Factors: RUNX1, GATA2, CEBPA, ETV6, WT1
  • Signal Transduction Genes: FLT3, JAK2, NRAS, KRAS, PTPN11
  • Tumor Suppressors: TP53, NF1, PHF6
  • Cohesin Complex Genes: STAG2, SMC1A
  • Fusion Genes: ETV6, JAK2, KMT2A, MLL, MECOM, RARA, RUNX1

Who Should Consider This Test?

The Oncomine MDS Panel Test is recommended for individuals presenting with:

  • Unexplained cytopenias (low blood counts)
  • Persistent anemia, neutropenia, or thrombocytopenia
  • Abnormal bone marrow morphology
  • Dysplastic changes in blood cells
  • Increased blasts in peripheral blood or bone marrow
  • Suspected transformation to acute myeloid leukemia
  • Family history of MDS or hematologic malignancies
  • Monitoring disease progression in established MDS cases

Clinical Benefits of Genetic Testing

Comprehensive genetic profiling through the Oncomine MDS Panel offers numerous clinical advantages:

  • Accurate Diagnosis: Differentiates MDS from other bone marrow failure syndromes
  • Prognostic Stratification: Identifies high-risk genetic features that impact survival
  • Treatment Guidance: Informs selection of appropriate therapies including hypomethylating agents
  • Disease Monitoring: Tracks clonal evolution and treatment response
  • Transplant Planning: Assists in timing and preparation for stem cell transplantation
  • Risk Assessment: Evaluates progression risk to acute myeloid leukemia

Understanding Your Test Results

Your comprehensive genetic report will provide detailed information about detected mutations, their clinical significance, and therapeutic implications. Key aspects include:

  • Mutation Profile: Specific genetic alterations identified in your sample
  • Variant Allele Frequency: Percentage of cells carrying each mutation
  • Clinical Significance: Interpretation of how mutations impact disease course
  • Therapeutic Implications: Potential targeted treatment options
  • Prognostic Information: Risk stratification based on genetic findings
  • Follow-up Recommendations: Guidance for ongoing monitoring and management

Test Pricing and Availability

Test Name Discount Price Regular Price
Oncomine Myelodysplastic Syndrome MDS Panel Test $1024 USD $1138 USD

Nationwide Testing Availability

We have diagnostic centers conveniently located across the United States, serving major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art molecular diagnostics laboratories ensure consistent, high-quality testing results with rapid turnaround times.

Sample Requirements and Processing

Sample Type: 3 mL (2 mL minimum) whole blood OR bone marrow in 1 lavender top (EDTA) tube

Shipping Instructions: Ship refrigerated. DO NOT FREEZE

Required Documentation: Duly filled NGS Test Requisition Form (Form 40) is mandatory

Turnaround Time: Samples accepted by 1st/16th of every month; Reports delivered 15th/30th of same month

Take Control of Your Hematologic Health

Early and accurate genetic characterization of myelodysplastic syndromes can significantly impact treatment outcomes and quality of life. The Oncomine MDS Panel Test provides the comprehensive genetic information needed for personalized management strategies. Don’t wait to get the answers you need for optimal care.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your Oncomine MDS Panel Test and take the first step toward comprehensive genetic understanding of your hematologic condition.

SKU: 1805 Category:

Related products